Overview

Post Intravitreal Injection Topical NSAID vs. Patching

Status:
Unknown status
Trial end date:
2019-06-03
Target enrollment:
Participant gender:
Summary
A prospective randomized trial, to evaluate post-injection comfort measures comparing topical NSAID (nepafenac 0.3% suspension) and patching.
Phase:
Phase 4
Details
Lead Sponsor:
The New York Eye & Ear Infirmary
Treatments:
Carboxymethylcellulose Sodium
Nepafenac